Immunotherapy of brain metastases: breaking a “dogma”

被引:0
作者
Anna Maria Di Giacomo
Monica Valente
Alfonso Cerase
Maria Fortunata Lofiego
Francesca Piazzini
Luana Calabrò
Elisabetta Gambale
Alessia Covre
Michele Maio
机构
[1] Center for Immuno-Oncology,Department of Oncology
[2] Medical Oncology and Immunotherapy,Unit of Neuroradiology
[3] University Hospital of Siena,undefined
[4] University Hospital,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词
Brain metastases; Immune checkpoint(s); Cancer immunotherapy; Lung cancer; Magnetic resonance imaging; Melanoma; Neuroradiology; Tumor microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoclonal antibodies to immune check-point(s) across a wide range of tumor types, patients with brain disease were invariably excluded from clinical trials with these agents. Recent insights on the immune landscape of the central nervous system, as well as of the brain tumor microenvironment, are shedding light on the immune-biology of brain metastases.
引用
收藏
相关论文
共 452 条
  • [1] Ostrom QT(2018)Brain metastases: epidemiology Handb Clin Neurol 149 27-42
  • [2] Wright CH(2016)Update in the management of brain metastases Neuro-Oncology 18 1043-1065
  • [3] Barnholtz-Sloan JS(2018)Systemic therapy for brain metastases Handb Clin Neurol 149 137-153
  • [4] Arvold ND(2017)Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma Neuro-Oncology 19 i1-i24
  • [5] Lee EQ(2017)Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study Neuro-Oncology 19 1511-1521
  • [6] Mehta MP(2019)Brain metastases Nat Rev Dis Primers 5 5-341
  • [7] Margolin K(2019)The promise of Immuno-oncology implications for defining the value of cancer treatment J Immunother Cancer 7 129-e122
  • [8] Alexander BM(2017)The microenvironmental landscape of brain tumors Cancer Cell 31 326-33
  • [9] Lin NU(2016)Immune checkpoint inhibitors in brain metastases: from biology to treatment Am Soc Clin Oncol Educ Book 35 e116-1437
  • [10] Venur VA(2019)Combination of CTLA-4 and PD-1 blockers for treatment of cancer J Exp Clin Cancer Res 38 255-5299